Wall Street brokerages forecast that SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) will report sales of $22.37 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for SI-BONE’s earnings. The highest sales estimate is $22.40 million and the lowest is $22.34 million. SI-BONE posted sales of $20.44 million during the […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) insider Anthony J. Recupero sold 577 shares of the business’s stock in a transaction on Monday, April 18th. The stock was sold at an average price of $19.92, for a total value of $11,493.84. Following the completion of the transaction, the insider now directly owns 179,545 shares of the […]
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) has been assigned an average recommendation of “Buy” from the ten brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year price target among brokers that […]
Zacks Investment Research upgraded shares of SI-BONE (NASDAQ:SIBN – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Friday, Zacks.com reports. According to Zacks, “SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint […]
Private Ocean LLC reduced its position in SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) by 35.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,156 shares of the company’s stock after selling 1,170 shares during the period. Private Ocean LLC’s holdings in […]